Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors.

Chuang P, Langone AJ
Am J Ther. 2007 14 (5): 438-41

PMID: 17890931 · DOI:10.1097/01.mjt.0000209693.83065.a6

MeSH Terms (16)

Adult Aged Anticholesteremic Agents Azetidines Cholesterol, LDL Ezetimibe Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Hyperlipidemias Kidney Transplantation Male Middle Aged Practice Guidelines as Topic Retrospective Studies Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links